Panbela Therapeutics Stock Revenue
| PBLADelisted Stock | USD 2.06 0.11 5.07% |
Panbela Therapeutics fundamentals help investors to digest information that contributes to Panbela Therapeutics' financial success or failures. It also enables traders to predict the movement of Panbela Stock. The fundamental analysis module provides a way to measure Panbela Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Panbela Therapeutics stock.
Panbela |
Panbela Therapeutics Company Revenue Analysis
Panbela Therapeutics' Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
CompetitionBased on the latest financial disclosure, Panbela Therapeutics reported 0.0 of revenue. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The revenue for all United States stocks is 100.0% higher than that of the company.
Panbela Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Panbela Therapeutics' direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Panbela Therapeutics could also be used in its relative valuation, which is a method of valuing Panbela Therapeutics by comparing valuation metrics of similar companies.Panbela Therapeutics is currently under evaluation in revenue category among its peers.
Panbela Fundamentals
| Return On Equity | -7.98 | ||||
| Return On Asset | -1.92 | ||||
| Current Valuation | 8.64 M | ||||
| Shares Outstanding | 3.48 M | ||||
| Shares Owned By Institutions | 0.59 % | ||||
| Number Of Shares Shorted | 106.97 K | ||||
| Price To Book | 3.22 X | ||||
| EBITDA | (34.76 M) | ||||
| Net Income | (34.93 M) | ||||
| Cash And Equivalents | 2.53 M | ||||
| Cash Per Share | 0.12 X | ||||
| Total Debt | 6.84 M | ||||
| Current Ratio | 0.56 X | ||||
| Book Value Per Share | (16.57) X | ||||
| Cash Flow From Operations | (15.28 M) | ||||
| Short Ratio | 0.07 X | ||||
| Earnings Per Share | (157.02) X | ||||
| Target Price | 410.0 | ||||
| Beta | 0.83 | ||||
| Market Capitalization | 3.93 M | ||||
| Total Asset | 4.98 M | ||||
| Retained Earnings | (91.09 M) | ||||
| Working Capital | (6.06 M) | ||||
| Z Score | -49.78 | ||||
| Net Asset | 4.98 M |
About Panbela Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Panbela Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Panbela Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Panbela Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Consideration for investing in Panbela Stock
If you are still planning to invest in Panbela Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Panbela Therapeutics' history and understand the potential risks before investing.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |